Manuscripts
Showing 1554 manuscripts.
Screening for Sexually Transmitted Infections in Antenatal Care is Especially Important Among HIV-infected Women
Citation
SH Vermund. Screening for Sexually Transmitted Infections in Antenatal Care is Especially Important Among HIV-infected Women. Sexually Transmitted Diseases. 2015. 42: 566-568. PMID: 26372928Year
2015
Journal
Sexually Transmitted Diseases
Chlamydia and Gonorrhea in HIV-infected Pregnant Women and Adverse Infant Outcomes
Citation
Jiahong Xu, Jorge Pinto, Bonnie Ank, Marisa Mussi-Pinhata, Claire C. Bristow, Mariana Ceriotto, Mariza G Morgado, Daisy Maria Machado, D. Heather Watts, Yvonne J Bryson, Fred Weir, Beatriz Grinsztejn, David Persing, Francisco I Bastos, Lynne M. Mofenson, George Siberry, Valdilea G. Veloso, Karin Neilsen-Saines for the NICHD HPTN 040 Study Team, Jose Henrique Pilotto, Esau Joao, Glenda Gray, Gerhard Theron, Breno Santos, Kristina Adachi, Rosana Fonseca, Jeffrey D Klasner, Regis Kreitchmann. Chlamydia and Gonorrhea in HIV-infected Pregnant Women and Adverse Infant Outcomes. Sexually Transmitted Diseases. 2015. 42: 554-65. PMID: 26372927Year
2015
Journal
Sexually Transmitted Diseases
Changing Trends in Complications and Mortality among US Youth and Young Adults with
HIV Infection in the Era of Combination Antiretroviral Therapy
Citation
Miriam Chernoff, Mark Abzug, Myron Levin, George Seage, James Oleske, Murli Purswani, Rohan Hazra, Shirley Traite, Bonnie Zimmer, Russell Van Dyke for the IMPAACT P1074 team, Gayatri Mirani, Paige Williams. Changing Trends in Complications and Mortality among US Youth and Young Adults with HIV Infection in the Era of Combination Antiretroviral Therapy. Clinical Infectious Diseases. 2015. 61: 1850-1861.Year
2015
Journal
Clinical Infectious Diseases
Pharmacokinetics and 48-Week Safety and Efficacy of Raltegravir for Oral Suspension in Human Immunodeficiency Virus Type-1-Infected Children 4 Weeks to 2 Years of Age
Citation
EP Acosta, H Teppler, B Homony, B Graham, T Fenton, X Xu, ML Rizk, SA Spector, LM Frenkel, C Worrell, E Handelsman, A Wiznia, S Nachman, C Alvero. Pharmacokinetics and 48-Week Safety and Efficacy of Raltegravir for Oral Suspension in Human Immunodeficiency Virus Type-1-Infected Children 4 Weeks to 2 Years of Age. Journal of Pediatric Infectious Disease Society. 2015. 4: e76-83. PMID: 26582887Year
2015
Journal
Journal of Pediatric Infectious Disease Society
Study
P1066
Population Pharmacokinetic Analysis of Raltegravir Pediatric Formulations in HIV-infected Children 4 weeks to 18 years of age
Citation
C Bennetto-Hood, L Wenning, H Teppler, B Homony, B Graham, C Fry, S Nachman, A Wiznia, C Worrell, B Smith, EP Acosta, ML Rizk, L Du. Population Pharmacokinetic Analysis of Raltegravir Pediatric Formulations in HIV-infected Children 4 weeks to 18 years of age. 2015. PMID: 25753401Year
2015
Study
P1066
Factors associated with lack of viral suppression at delivery among highly active antiretroviral therapy-naive women with HIV: a cohort study
Citation
Deborah Kacanek, Michael D Hughes, Arlene Bardeguez, Elizabeth Livingston, Alice Stek, David E Shapiro, Ruth Tuomala, Ingrid T Katz, Erin Leister. Factors associated with lack of viral suppression at delivery among highly active antiretroviral therapy-naive women with HIV: a cohort study. Annals of Internal Medicine. 2015. 162: 90-99. PMID: 25599347Year
2015
Journal
Annals of Internal Medicine
Fracture Risk by HIV Infection Status in Perinatally HIV-Exposed Children
Citation
D Jacobson, PACTG 219/219c, GK Siberry, H Li. Fracture Risk by HIV Infection Status in Perinatally HIV-Exposed Children. AIDS. 2014. 28: 247-250. PMID: 22471877Year
2014
Journal
AIDS
Study
1077HS, 1077BF
A Sensitive HPLC-MS/MS Method for the Determination of Dolutegravir in Human Plasma
Citation
P Savina, EP Acosta, C Bennetto-Hood, G Tabolt. A Sensitive HPLC-MS/MS Method for the Determination of Dolutegravir in Human Plasma. Journal of Chromatography. B, Analytical technologies in the biomedical and life sciences. 2014. 225-232. PMID: 24361860Year
2014
Journal
Journal of Chromatography. B, Analytical technologies in the biomedical and life sciences
Study
P1093
Predictors of Resolution and Persistence of Renal Laboratory Abnormalities in Pediatric HIV Infection
Citation
George R. Seage III, Murli R Purswani, Hans M.L. Spiegel, Gaston Zilleruelo, Carolyn Abibol, Barbara Heckman, Christopher B Ponce, James M Oleske, Charles D Mitchell, Miriam C. Chernoff. Predictors of Resolution and Persistence of Renal Laboratory Abnormalities in Pediatric HIV Infection. Pediatric Nephrology. 2014. 30: 153-165. PMID: 25149850Year
2014
Journal
Pediatric Nephrology